Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

COMPARISON OF THE BETA RECEPTOR BLOCKING PROPERTIES OF TWO ANALOGS OF DICHLOROISOPROTERENOL (DCI)

BERNARID LEVY
Journal of Pharmacology and Experimental Therapeutics July 1973, 186 (1) 123-133;
BERNARID LEVY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The beta receptor blocking properties of 1-(2',4'-dichlorophenyl)-2-isopropylaminoethanol (2,4-DCI) and 1-(2', 4'-dichlorophenyl)-2-t-butylaminoethanol (DCB) were determined in the anesthetized cat. Additional studies with DCB were conducted in anesthetized dogs. Both compounds blocked cardiac and vascular beta receptors in the cat at threshold doses of 0.03 mg/kg for DCB and 3 mg/kg for 2,4-DCI. Neither compound exerted significant intrinsic sympathomimetic or myocardial depressant activity. In dogs, DCB treatment reduced the fall in diastolic pressure, the positive inotropic effect, the positive chronotropic effect and the increase in femoral arterial blood flow induced by isoproterenol in the same dose range. No significant intrinsic sympathomimetic or myocardial depressant effects were evoked even after large doses of DCB. Placing the Cl groups at the 2,4 positions appears to eliminate the intrinsic sympathomimetic and myocardial depressant properties that are produced by the 3,4 substituted analog, dichloroisoproterenol (DCI). Substitution of a tertiary butyl group for an isopropyl group on the N of the ethanolamine side chain increases beta receptor blocking potency. Both DCB and 2,4-DCI were nonselective in exerting their beta receptor blocking effects on the parameters studied.

Footnotes

    • Received February 28, 1973.
    • Accepted April 4, 1973.
  • © 1972 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 186, Issue 1
1 Jul 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
COMPARISON OF THE BETA RECEPTOR BLOCKING PROPERTIES OF TWO ANALOGS OF DICHLOROISOPROTERENOL (DCI)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

COMPARISON OF THE BETA RECEPTOR BLOCKING PROPERTIES OF TWO ANALOGS OF DICHLOROISOPROTERENOL (DCI)

BERNARID LEVY
Journal of Pharmacology and Experimental Therapeutics July 1, 1973, 186 (1) 123-133;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

COMPARISON OF THE BETA RECEPTOR BLOCKING PROPERTIES OF TWO ANALOGS OF DICHLOROISOPROTERENOL (DCI)

BERNARID LEVY
Journal of Pharmacology and Experimental Therapeutics July 1, 1973, 186 (1) 123-133;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Ethnic Differences in N-Glucuronidation of Nicotine and Cotinine
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics